All In MedTech

FDA Clearance Tracker · P980053-S018

Durasphere Injectable Bulking Agent

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 25, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 25, 2021

Approved

Time to decision

59 days

Received Dec 28, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P980053-S018
Device name
Durasphere Injectable Bulking Agent
Applicant location
St. Paul, MN
Received
Dec 28, 2020
Decided
Feb 25, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P980053

Device type

Device class
Class III

Every decision under product code LNM

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Steris, 9303 West Broadway Ave., Brooklyn Park, MN 55445, a contract sterilizer.

Source documents

Other decisions for Carbon Medical Technologies, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.